Recently, some studies reported that several orphan G protein-coupled receptors (GPCRs), GPR41, GPR43, and GPR120, possess potential as fresh drug targets for disorders of metabolism, including T2D and obesity (70). The gene discussed is FFAR3; the disease is obesity disorder.